Gains in cancer survival at risk due to surge in multi-drug resistant superbugs
May 4, 2017
| By Mary Engel / Fred Hutch News Service
Antibiotics and other antimicrobials are unique among medications, a “shared resource” that we need to preserve, much as we steward our environment and natural resources, says Fred Hutch clinician-infectious disease researcher Dr. Catherine Liu. Overuse or misuse can lead to drug-resistant bugs that can then spread to new hosts and in some cases even spread their resistance genes to different microorganisms, posing a risk to society at large.
Technology prize allows study of vaginal bacterial strains
Sept. 27, 2010
The Fred Hutchinson Cancer Research Center Vaccine and Infectious Disease Division’s Fredricks Lab has won a BioFlux Innovation Award. Dr. Laura Sycuro, a postdoctoral research fellow in the lab, authored the winning submission which focuses on screening characterizing bacterial strains that form multicellular communities, also known as biofilms, during infections that affect women’s reproductive health.
Dr. David Fredricks of the Fred Hutchinson Cancer Research Center's Vaccine and Infectious Disease Division was recently granted a $2 million, three-year grant from the National Institutes of Health to create new technology for vaginal bacteria cultivation as part of NIH’s Human Microbiome Project.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.